The Effect of Low pH on Breast Cancer Resistance Protein (ABCG2)-Mediated Transport of Methotrexate, 7-Hydroxymethotrexate, Methotrexate Diglutamate, Folic Acid, Mitoxantrone, Topotecan, and Resveratrol in In Vitro Drug Transport Models

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Molecular Pharmacology

• Publication date

  2007-01-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1124/mol.106.028167PMID 17032904
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The human multidrug resistance protein MRP5 transports folates and can mediate cellular resistance against antifolates.

  2005cited by this paper
• Single amino acid (482) variants of the ABCG2 multidrug transporter: major differences in transport capacity and substrate recognition.

  2005cited by this paper
• Determination of the overlapping pKa values of resorcinol using UV-visible spectroscopy and DFT methods.

  2005influential reference
• Lack of an effect of breast cancer resistance protein (BCRP/ABCG2) overexpression on methotrexate polyglutamate export and folate accumulation in a human breast cancer cell line.

  2005cited by this paper
• Hypoxia‐Induced Acidification Causes Mitoxantrone Resistance Not Mediated by Drug Transporters in Human Breast Cancer Cells

  2005cited by this paper
• Function-dependent Conformational Changes of the ABCG2 Multidrug Transporter Modify Its Interaction with a Monoclonal Antibody on the Cell Surface*

  2005influential reference
• Human Breast Cancer Resistance Protein: Interactions with Steroid Drugs, Hormones, the Dietary Carcinogen 2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine, and Transport of Cimetidine

  2005influential reference
• ABCG2 harboring the Gly482 mutation confers high-level resistance to various hydrophilic antifolates.

  2005cited by this paper
• Single nucleotide polymorphisms modify the transporter activity of ABCG2

  2005cited by this paper
• Oligomerization of the human ABC transporter ABCG2: evaluation of the native protein and chimeric dimers.

  2005cited by this paper
• Recent advances in carrier-mediated intestinal absorption of water-soluble vitamins.

  2004influential reference
• Folate Deprivation Results in the Loss of Breast Cancer Resistance Protein (BCRP/ABCG2) Expression

  2004cited by this paper
• Interaction of the breast cancer resistance protein with plant polyphenols.

  2004cited by this paper
• A Prominent Low-pH Methotrexate Transport Activity in Human Solid Tumors

  2004influential reference
• Mechanism of the Pharmacokinetic Interaction between Methotrexate and Benzimidazoles

  2004cited by this paper
• Why do cancers have high aerobic glycolysis?

  2004cited by this paper
• Cancer Resistance Protein in Clinical Drug-Drug Interactions Methotrexate and Benzimidazoles : Potential Role for Breast Mechanism of the Pharmacokinetic Interaction between Updated

  2004cited by this paper
• Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2

  2004cited by this paper
• Transport of methotrexate, methotrexate polyglutamates, and 17beta-estradiol 17-(beta-D-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transport.

  2003influential reference
• Tumor acidity, ion trapping and chemotherapeutics. I. Acid pH affects the distribution of chemotherapeutic agents in vitro.

  2003influential reference
• Wild-type breast cancer resistance protein (BCRP/ABCG2) is a methotrexate polyglutamate transporter.

  2003influential reference
• Expression and functional characterization of human ABC transporter ABCG2 variants in insect cells.

  2003cited by this paper
• A functional study on polymorphism of the ATP-binding cassette transporter ABCG2: critical role of arginine-482 in methotrexate transport.

  2003influential reference
• Role Reversal for Anticancer Agents

  2002cited by this paper
• Characterization of Drug Transport, ATP Hydrolysis, and Nucleotide Trapping by the Human ABCG2 Multidrug Transporter

  2002cited by this paper
• Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C.

  2002cited by this paper
• Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cells.

  2001cited by this paper
• The cell transmembrane pH gradient in tumors enhances cytotoxicity of specific weak acid chemotherapeutics.

  2001cited by this paper
• Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues.

  2001cited by this paper
• Receptor- and Carrier-Mediated Transport Systems for Folates and Antifolates

  1999cited by this paper
• Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line.

  1999cited by this paper
• Antifolate Drugs in Cancer Therapy

  1999cited by this paper
• Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2.

  1999cited by this paper
• Advances in Brief Overexpression of the BCRP / MXR / ABCP Gene in a Topotecan-selected Ovarian Tumor Cell Line 1

  1999cited by this paper
• A multidrug resistance transporter from human MCF-7 breast cancer cells.

  1998influential reference
• Increased Activity of a Novel Low pH Folate Transporter Associated with Lipophilic Antifolate Resistance in Chinese Hamster Ovary Cells*

  1998influential reference
• Cellular pharmacokinetics and cytotoxicity of camptothecin and topotecan at normal and acidic pH.

  1997influential reference
• pH dependence of methotrexate transport by the reduced folate carrier and the folate receptor in L1210 leukemia cells. Further evidence for a third route mediated at low pH.

  1997influential reference
• Intracellular pH does not affect drug extrusion by P-glycoprotein.

  1996cited by this paper
• Changes in intra- or extracellular pH do not mediate P-glycoprotein-dependent multidrug resistance.

  1993cited by this paper
• Regulation of intracellular pH in tumor cell lines: influence of microenvironmental conditions.

  1992influential reference
• Equilibrium kinetics of the new experimental anti-tumour compound SK&F 104864-A in aqueous solution.

  1990cited by this paper
• Clinical pharmacokinetics : concepts and applications

  1989influential reference
• Acid pH in tumors and its potential for therapeutic exploitation.

  1989influential reference
• The regulation of cytoplasmic pH in human fibroblasts.

  1984influential reference
• A simple preparation of the methotrexate metabolites 7-hydroxymethotrexate and 4-deoxy-4-amino-N10-methylpteroic acid.

  1983cited by this paper
• Acidic dissociation constants of folic acid, dihydrofolic acid, and methotrexate.

  1977cited by this paper

• Phytochemical intervention in BCRP-driven cancer drug resistance: A comprehensive review.

  2025cites this paper
• Evaluation of BCRP-Related DDIs Between Methotrexate and Cyclosporin A Using Physiologically Based Pharmacokinetic Modelling

  2024cites this paper
• The pH-dependence of efflux ratios determined with bidirectional transport assays across cellular monolayers

  2024cites this paper
• A systems framework for investigating the roles of multiple transporters and their impact on drug resistance.

  2024cites this paper
• Multi drug resistance in Colorectal Cancer- approaches to overcome, advancements and future success

  2024cites this paper
• The role of glycolysis in tumorigenesis: From biological aspects to therapeutic opportunities

  2024cites this paper
• Warburg effect in colorectal cancer: the emerging roles in tumor microenvironment and therapeutic implications

  2022cites this paper
• Blood–Brain Barrier Transporters: Opportunities for Therapeutic Development in Ischemic Stroke

  2022cites this paper
• Quantification of doping state of redox sensitive nanoparticles for probing the invasiveness of cancer cells using surface enhanced Raman scattering

  2022cites this paper
• Pharmacogenomics of drug transporters for antiretroviral long-acting pre-exposure prophylaxis for HIV

  2022influential citation
• Glycolysis-induced drug resistance in tumors—A response to danger signals?

  2021cites this paper
• Why may citrate sodium significantly increase the effectiveness of transarterial chemoembolization in hepatocellular carcinoma?

  2021cites this paper
• A new porphyrin as selective substrate-based inhibitor of breast cancer resistance protein (BCRP/ABCG2).

  2021cites this paper
• Metabolomic and transcriptomic analysis reveals endogenous substrates and metabolic adaptation in rats lacking Abcg2 and Abcb1a transporters

  2021cites this paper
• Role of the Abcg2 transporter in plasma levels and tissue accumulation of the anti-inflammatory tolfenamic acid in mice.

  2021cites this paper
• A pharmacogenetics study of platinum-based chemotherapy in lung cancer: ABCG2 polymorphism and its genetic interaction with SLC31A1 are associated with response and survival

  2021cites this paper
• The bitter taste receptor TAS2R14 regulates resveratrol transport across the human blood-cerebrospinal fluid barrier.

  2020cites this paper
• P-Glycoprotein 1 Affects Chemoactivities of Resveratrol against Human Colorectal Cancer Cells

  2019cites this paper
• Acidity is one of the main mechanism for hypoxia triggering chemoresistance to mitoxanthrone (MX) in the human breast cancer MCF-7 cell line

  2019influential citation
• Drug Monitoring in Breast Milk: Novel Insights on Pharmacokinetics and Infant Exposure Estimates

  2018cites this paper
• Elucidation of the Intestinal Absorption Mechanism of Loganin in the Human Intestinal Caco-2 Cell Model

  2018cites this paper
• How the Warburg effect supports aggressiveness and drug resistance of cancer cells?

  2018cites this paper
• Ochratoxin A transport by the human breast cancer resistance protein (BCRP), multidrug resistance protein 2 (MRP2), and organic anion‐transporting polypeptides 1A2, 1B1 and 2B1

  2017cites this paper
• The effects of dietary and herbal phytochemicals on drug transporters☆

  2017cites this paper
• Overview of experimental and computational methods for the determination of the pKa values of 5-fluorouracil, cyclophosphamide, ifosfamide, imatinib and methotrexate

  2017cites this paper
• Therapeutic implications of tumor interstitial acidification.

  2017cites this paper
• Pathobiology and Therapeutic Implications of Tumor Acidosis.

  2017cites this paper
• Contrasting roles of the ABCG2 Q141K variant in prostate cancer

  2017cites this paper
• Pharmaceutical versatility of cationic niosomes derived from amino acid-based surfactants: Skin penetration behavior and controlled drug release.

  2017cites this paper
• Single-cell pH imaging and detection for pH profiling and label-free rapid identification of cancer-cells

  2017cites this paper
• Pharmacokinetic Interactions Between Isavuconazole and the Drug Transporter Substrates Atorvastatin, Digoxin, Metformin, and Methotrexate in Healthy Subjects

  2016cites this paper
• Protective mechanisms of resveratrol against methotrexate‐induced renal damage may involve BCRP/ABCG2

  2016cites this paper
• Microdialysis-directed Intra-tumor Pharmacokinetic Modeling of Methotrexate in Mice and Humans.

  2016cites this paper
• Altered pH gradient at the plasma membrane of osteosarcoma cells is a key mechanism of drug resistance

  2016cites this paper
• A role for ABCG2 beyond drug transport: Regulation of autophagy

  2016cites this paper
• Polymeric micelles stabilized by polyethylenimine–copper (C2H5N–Cu) coordination for sustained drug release

  2016cites this paper
• Physiological scaling factors and mechanistic models for prediction of renal clearance from in vitro data

  2016cites this paper
• Towards a fully mechanistic prediction of oral drug absorption: Investigating intestinal transporter abundance and function relationships

  2015cites this paper
• Preclinical Pharmacologic Evaluation of Pralatrexate and Romidepsin Confirms Potent Synergy of the Combination in a Murine Model of Human T-cell Lymphoma

  2015cites this paper
• Interplay of Breast Cancer Resistance Protein (BCRP) and Metabolizing Enzymes.

  2015cites this paper
• Prediction of brain target site concentrations on the basis of CSF PK: Impact of mechanisms of blood-to-brain transport and within brain distribution

  2015cites this paper
• The antiepileptic drug lamotrigine is a substrate of mouse and human breast cancer resistance protein (ABCG2).

  2015cites this paper
• The intestinal absorption of folates.

  2014cites this paper
• Multi-fluorescent micro-sensor for accurate measurement of pH and temperature variations in micro-environments

  2014cites this paper
• Prediction of methotrexate CNS distribution in different species - influence of disease conditions.

  2014cites this paper
• The role of a Schiff base scaffold, N-(2-hydroxy acetophenone) glycinate-in overcoming multidrug resistance in cancer.

  2014cites this paper
• High risk of embryo-fetal toxicity: placental transfer of T-2 toxin and its major metabolite HT-2 toxin in BeWo cells.

  2014cites this paper
• A Novel Pathway for Arsenic Elimination: Human Multidrug Resistance Protein 4 (MRP4/ABCC4) Mediates Cellular Export of Dimethylarsinic Acid (DMAV) and the Diglutathione Conjugate of Monomethylarsonous Acid (MMAIII)

  2014cites this paper
• Dietary polyacetylenes of the falcarinol type are inhibitors of breast cancer resistance protein (BCRP/ABCG2).

  2014cites this paper
• Identification et mécanisme d'action de modulateurs sélectifs du transporteur ABCG2 responsable de la chimiorésistance de cellules cancéreuses

  2014cites this paper
• Structure and function of BCRP, a broad specificity transporter of xenobiotics and endobiotics

  2014cites this paper
• The effect of BCRP , MDR 1 and OATP 1 B 3 on the antitumor efficacy of the lipophilic camptothecin AR-67 in vitro

  2013cites this paper
• The Effect of Breast Cancer Resistance Protein, Multidrug Resistant Protein 1, and Organic Anion-Transporting Polypeptide 1B3 on the Antitumor Efficacy of the Lipophilic Camptothecin 7-t-Butyldimethylsilyl-10-Hydroxycamptothecin (AR-67) In Vitro

  2013cites this paper
• The expression of V-ATPase is associated with drug resistance and pathology of non-small-cell lung cancer

  2013cites this paper
• Elucidation of Monomerization Effect of PVP on Chlorin e6 Aggregates by Spectroscopic, Chemometric, Thermodynamic and Molecular Simulation Studies

  2013cites this paper
• Predicting substrates of the human breast cancer resistance protein using a support vector machine method

  2013cites this paper
• ABCG2: recent discovery of potent and highly selective inhibitors.

  2013cites this paper
• Interplay between metabolism and transport of resveratrol

  2013cites this paper
• Review Special Focu S: combating Re S i S tance: oncology

  2013cites this paper
• PRECLINICAL AND CLINICAL DEVELOPMENT OF THE LIPOPHILIC CAMPTOTHECIN ANALOGUE AR-67

  2013cites this paper
• Regulation, Function, and Clinical Relevance of ABCG2 in Prostate Cancer

  2013cites this paper
• A pH sensitive ratiometric fluorophore and its application for monitoring the intracellular and extracellular pHs simultaneously.

  2013cites this paper
• The role of ABC and SLC transporters in the pharmacokinetics of dietary and herbal phytochemicals and their interactions with xenobiotics.

  2012cites this paper
• ABCG2/V-ATPase was associated with the drug resistance and tumor metastasis of esophageal squamous cancer cells

  2012cites this paper
• Contribution of tumoral and host solute carriers to clinical drug response.

  2012influential citation
• Methoxy stilbenes as potent, specific, untransported, and noncytotoxic inhibitors of breast cancer resistance protein.

  2012cites this paper
• Localization and Functional Characterization of the Rat Oatp4c1 Transporter in an In Vitro Cell System and Rat Tissues

  2012cites this paper
• Involvement of Multiple Transporters-mediated Transports in Mizoribine and Methotrexate Pharmacokinetics

  2012cites this paper
• ABCG2 functions as a general phytoestrogen sulfate transporter in vivo

  2012cites this paper
• Lack of effect of oral administration of resveratrol in LPS-induced systemic inflammation

  2011cites this paper
• Targeting the multidrug ABCG2 transporter with flavonoidic inhibitors: in vitro optimization and in vivo validation.

  2011cites this paper
• In vitro and in vivo evidence for the importance of breast cancer resistance protein transporters (BCRP/MXR/ABCP/ABCG2).

  2011cites this paper
• Mechanisms of membrane transport of folates into cells and across epithelia.

  2011cites this paper
• Oral Bioavailability and Disposition of Phytochemicals

  2011cites this paper
• ADME properties of herbal medicines in humans: evidence, challenges and strategies.

  2011cites this paper
• Validation of membrane vesicle-based breast cancer resistance protein and multidrug resistance protein 2 assays to assess drug transport and the potential for drug–drug interaction to support regulatory submissions

  2011cites this paper
• Dysregulated pH: a perfect storm for cancer progression

  2011cites this paper
• pH-Dependent Transport of Pemetrexed by Breast Cancer Resistance Protein

  2011influential citation
• A comprehensive study demonstrating that p-glycoprotein function is directly affected by changes in pH: implications for intestinal pH and effects on drug absorption.

  2011cites this paper
• Oral sulfasalazine as a clinical BCRP probe substrate: pharmacokinetic effects of genetic variation (C421A) and pantoprazole coadministration.

  2010cites this paper
• ACTIVE EFFLUX TRANSPORT AND CNS DISTRIBUTION OF THE NOVEL ANTIFOLATE PEMETREXED

  2010cites this paper
• Interactions of dietary phytochemicals with ABC transporters: possible implications for drug disposition and multidrug resistance in cancer

  2010cites this paper
• Involvement of breast cancer resistance protein (BCRP1/ABCG2) in the bioavailability and tissue distribution of trans-resveratrol in knockout mice.

  2010cites this paper
• Multidrug Resistance Proteins Restrain the Intestinal Absorption of trans-Resveratrol

  2010cites this paper
• Multidrug resistance proteins restrain the intestinal absorption of trans-resveratrol in rats.

  2010cites this paper
• Molecular Expression and Functional Evidence of a Drug Efflux Pump (BCRP) in Human Corneal Epithelial Cells

  2009cites this paper
• Chapter 9 Physiological and pharmacological roles of ABCG 2 ( BCRP ) : recent findings in Abcg 2 knockout mice

  2009cites this paper
• Pharmacological functions of multidrug transporters: studies employing combination transporter knockout mice

  2009cites this paper
• Ins and outs of the ABCG2 multidrug transporter: an update on in vitro functional assays.

  2009cites this paper
• Compartment-specific roles of ATP-binding cassette transporters define differential topotecan distribution in brain parenchyma and cerebrospinal fluid.

  2009cites this paper
• Organic Anion-Transporting Polypeptide 1B1 Mediates Transport of Gimatecan and BNP1350 and Can Be Inhibited by Several Classic ATP-Binding Cassette (ABC) B1 and/or ABCG2 Inhibitors

  2009cites this paper
• Transport of Diclofenac by Breast Cancer Resistance Protein (ABCG2) and Stimulation of Multidrug Resistance Protein 2 (ABCC2)-Mediated Drug Transport by Diclofenac and Benzbromarone

  2009influential citation
• Intestinal Breast Cancer Resistance Protein (BCRP)/Bcrp1 and Multidrug Resistance Protein 3 (MRP3)/Mrp3 Are Involved in the Pharmacokinetics of Resveratrol

  2009influential citation
• Pengaruh Pengasaman terhadap Fotodegradasi Klorofil a

  2009cites this paper
• Functionally Overlapping Roles of Abcg2 (Bcrp1) and Abcc2 (Mrp2) in the Elimination of Methotrexate and Its Main Toxic Metabolite 7-Hydroxymethotrexate In vivo

  2009cites this paper
• Kinetic characterization of sulfasalazine transport by human ATP-binding cassette G2.

  2009cites this paper
• Physiological and pharmacological roles of ABCG2 (BCRP): recent findings in Abcg2 knockout mice.

  2009cites this paper
• Untersuchungen zur Bedeutung der Sulfonylharnstoffrezeptoren für die spezifische Induktion von Apoptose nach Behandlung mit Glibenclamid oder Resveratrol

  2008cites this paper
• Investigation of interactions between ABC transporters and their lipid environment - Effect of membrane cholesterol content on the function of human ABCG2 (BCRP/MXR)

  2008cites this paper
• Leflunomide and its metabolite A771726 are high affinity substrates of BCRP: implications for drug resistance

  2008cites this paper